The North America Cell-based Assays Market would witness market growth of 7.5% CAGR during the forecast period (2022-2028).
Phenotypic screening of chemicals in a humanized multicellular environment generates more detailed data, allowing a more rapid translation of findings into clinical practice. Using cells derived from blood, tissue, or differentiated stem cells, human primary cell-based assays, like cell viability assays, cell proliferation assays, and GPCR assays, were developed for high-content analysis in several distinct disease area indications.
These assays include cell viability assays, cell proliferation assays, and GPCR assays. These high-throughput assays speed up the process of drug discovery by giving the most promising candidate in the biological context that matters the most. Drug development has progressed from a limited target-based screening in a basic cell-based assay that had little physiological relevance to multicellular cell-based biochemical and functional assays in disease-relevant platforms.
Cell-based assays for each stage of the drug development process have been developed in recent years to offer a deeper comprehension of the intricate interactions to researchers that take place between the networks and pathways that are a part of these cellular processes. Assays may be built to best simulate the disease state if the patient has access to a variety of cell types and are able to use both existing and innovative technologies.
This will lead to increased performance in translational research. In both biomedical research and drug discovery screening applications, cellular assays, also known as cell-based assays, can be utilized to efficiently assess biological activity, cytotoxicity, biochemical processes, and off-target interactions.
Cancer has a significant impact on society throughout the United States. Cancer statistics reflect what occurs in big populations and provide a temporal picture of the societal burden of cancer. According to the National Cancer Institute, In the United States, an anticipated 1,806,590 new instances of cancer were identified in 2020, and 606,520 people died due to the disease. Breast cancer, colon and rectum cancer, lung and bronchus cancer, bladder cancer, prostate cancer, melanoma of the skin, kidney and renal pelvis cancer, non-Hodgkin lymphoma, endometrial cancer, leukemia, thyroid cancer, pancreatic cancer, and liver cancer are the most prevalent types of cancer.
The US market dominated the North America Cell-based Assays Market by Country in 2021; thereby, achieving a market value of $7.2 billion by 2028. The Canada market is experiencing a CAGR of 10% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 9% during (2022 - 2028).
Based on Application, the market is segmented into Drug Discovery, Basic Research and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on Products & Services, the market is segmented into Assay Kits, Reagents, Microplates, Probes & Labels, Instruments & Software and Cell Lines. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cell-based Assays Market is Estimated to reach $24.9 Billion by 2028, at a CAGR of 8.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck Group, Promega Corporation and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Drug Discovery
- Basic Research
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
By Products & Services
- Assay Kits
- Reagents
- Microplates
- Probes & Labels
- Instruments & Software
- Cell Lines
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Charles River Laboratories International, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Lonza Group AG
- Merck Group
- Promega Corporation
- Thermo Fisher Scientific, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cell-based Assays Market, by Application
1.4.2 North America Cell-based Assays Market, by End User
1.4.3 North America Cell-based Assays Market, by Products & Services
1.4.4 North America Cell-based Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2021, Jun) Leading Players
Chapter 4. North America Cell-based Assays Market by Application
4.1 North America Drug Discovery Market by Country
4.2 North America Basic Research Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Cell-based Assays Market by End-use
5.1 North America Pharmaceutical & Biotechnology Companies Market by Country
5.2 North America Academic & Research Institutes Market by Country
5.3 North America Contract Research Organizations (CROs) Market by Country
Chapter 6. North America Cell-based Assays Market by Products & Services
6.1 North America Assay Kits Market by Country
6.2 North America Reagents Market by Country
6.3 North America Microplates Market by Country
6.4 North America Probes & Labels Market by Country
6.5 North America Instruments & Software Market by Country
6.6 North America Cell Lines Market by Country
Chapter 7. North America Cell-based Assays Market by Country
7.1 US Cell-based Assays Market
7.1.1 US Cell-based Assays Market by Application
7.1.2 US Cell-based Assays Market by End-use
7.1.3 US Cell-based Assays Market by Products & Services
7.2 Canada Cell-based Assays Market
7.2.1 Canada Cell-based Assays Market by Application
7.2.2 Canada Cell-based Assays Market by End-use
7.2.3 Canada Cell-based Assays Market by Products & Services
7.3 Mexico Cell-based Assays Market
7.3.1 Mexico Cell-based Assays Market by Application
7.3.2 Mexico Cell-based Assays Market by End-use
7.3.3 Mexico Cell-based Assays Market by Products & Services
7.4 Rest of North America Cell-based Assays Market
7.4.1 Rest of North America Cell-based Assays Market by Application
7.4.2 Rest of North America Cell-based Assays Market by End-use
7.4.3 Rest of North America Cell-based Assays Market by Products & Services
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Approvals and Trials:
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Geographical Expansions:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.5.4.2 Acquisition and Mergers:
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
TABLE 1 North America Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 2 North America Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell-based Assays Market
TABLE 4 Product Launches And Product Expansions– Cell-based Assays Market
TABLE 5 Acquisition and Mergers– Cell-based Assays Market
TABLE 6 Geographical Expansions – Cell-based Assays Market
TABLE 7 Approvals and Trials – Cell-based Assays Market
TABLE 8 North America Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 9 North America Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 10 North America Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Basic Research Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Basic Research Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 15 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 16 North America Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 17 North America Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 18 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 25 North America Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 26 North America Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 27 North America Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Reagents Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Reagents Market by Country, 2022 - 2028, USD Million
TABLE 30 North America Microplates Market by Country, 2018 - 2021, USD Million
TABLE 31 North America Microplates Market by Country, 2022 - 2028, USD Million
TABLE 32 North America Probes & Labels Market by Country, 2018 - 2021, USD Million
TABLE 33 North America Probes & Labels Market by Country, 2022 - 2028, USD Million
TABLE 34 North America Instruments & Software Market by Country, 2018 - 2021, USD Million
TABLE 35 North America Instruments & Software Market by Country, 2022 - 2028, USD Million
TABLE 36 North America Cell Lines Market by Country, 2018 - 2021, USD Million
TABLE 37 North America Cell Lines Market by Country, 2022 - 2028, USD Million
TABLE 38 North America Cell-based Assays Market by Country, 2018 - 2021, USD Million
TABLE 39 North America Cell-based Assays Market by Country, 2022 - 2028, USD Million
TABLE 40 US Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 41 US Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 42 US Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 43 US Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 44 US Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 45 US Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 46 US Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 47 US Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 48 Canada Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 49 Canada Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 50 Canada Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 51 Canada Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 52 Canada Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 53 Canada Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 54 Canada Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 55 Canada Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 56 Mexico Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 57 Mexico Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 58 Mexico Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 59 Mexico Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 60 Mexico Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 61 Mexico Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 62 Mexico Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 63 Mexico Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 64 Rest of North America Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 65 Rest of North America Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 66 Rest of North America Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 67 Rest of North America Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 68 Rest of North America Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 69 Rest of North America Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 70 Rest of North America Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 71 Rest of North America Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 72 Key information – Becton, Dickinson and Company
TABLE 73 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 74 Key Information – Thermo Fisher Scientific, Inc.
TABLE 75 Key Information – Bio-Rad Laboratories, Inc.
TABLE 76 key information – Charles River Laboratories International, Inc.
TABLE 77 Key Information – Danaher Corporation
TABLE 78 key Information – Merck GrouP
TABLE 79 Key Information – Lonza Group AG
TABLE 80 Key Information – Corning Incorporated
TABLE 81 key Information – Promega Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Becton, Dickinson and Company
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 7 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 8 Recent strategies and developments: Bio-Rad Laboratories, Inc.
FIG 9 Recent strategies and developments: Charles River Laboratories
FIG 10 Recent strategies and developments: Promega Corp.